SCHEMBL26435652

SCHEMBL26435652

c1ccc(-n2c3ccccc3c3c(-c4ccc(-c5nc(-c6cccc(-c7cccc8ccc9ccccc9c78)c6)nc(-c6cccc7c6oc6ccccc67)n5)cc4)cccc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.38
MAPT P10636 5/20 0.33
SIRT2 Q8IXJ6 1/20 0.33
SIRT1 Q96EB6 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
PRKDC P78527 2/20 0.32
PTGES2 Q9H7Z7 1/20 0.32
GGPS1 O95749 1/20 0.32
KDM4E B2RXH2 3/20 0.31
TSHR P16473 3/20 0.31
HSD17B10 Q99714 3/20 0.31
MAPK1 P28482 2/20 0.31
LMNA P02545 2/20 0.31
ALDH1A1 P00352 3/20 0.31
POLB P06746 1/20 0.31
TP53 P04637 1/20 0.31
HPGD P15428 1/20 0.31
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435615 0.97 ALOX5 (0.36) ALOX5MAPTSIRT2SIRT1NPSR1
SCHEMBL26435147 0.94 ALOX5 (0.35) ALOX5MAPTSIRT2SIRT1NPSR1
SCHEMBL26435571 0.92 ALOX5 (0.37) ALOX5MAPTNPSR1PRKDCPTGES2
SCHEMBL26435559 0.91 ALOX5 (0.38) ALOX5SIRT2SIRT1PRKDCPTGES2
SCHEMBL26435709 0.91 ALOX5 (0.36) ALOX5MAPTSIRT2SIRT1PRKDC
SCHEMBL26435710 0.91 ALOX5 (0.36) ALOX5MAPTSIRT2SIRT1PRKDC
SCHEMBL26435714 0.91 ALOX5 (0.38) ALOX5MAPTSIRT2SIRT1NPSR1
SCHEMBL23947801 0.91 ALOX5 (0.40) ALOX5MAPTNPSR1PRKDCPTGES2
SCHEMBL23947914 0.91 ALOX5 (0.40) ALOX5MAPTSIRT2SIRT1NPSR1
SCHEMBL21964940 0.91 ALOX5 (0.43) ALOX5MAPTNPSR1PRKDCPTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALOX5 1266/4885MAPT 2425/4885SIRT2 3665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.